Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism

Journal of Alzheimer's Disease

Volumn 38, Issue 4, 2014, Pages 747-752

  Carecchio, Miryam ^a   Galimberti, Daniela ^b   Fenoglio, Chiara ^b   Serpente, Maria ^b   Scarpini, Elio ^b   Comi, Cristoforo ^a   Terazzi, Emanuela ^a   Cantello, Roberto ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Atypical; DAT Scan; Frontotemporal dementia; Parkinsonism; Progranulin

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; IOFLUPANE I 123; PROGRANULIN; QUETIAPINE;

ADL DISABILITY; ADULT; AMNESIA; ARTICLE; BRAIN ATROPHY; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; ECHOLALIA; FOLLOW UP; GENE MUTATION; HUMAN; HYPERSEXUALITY; LANGUAGE DISABILITY; LEFT HEMISPHERE; MALE; MEDICAL HISTORY; MUSCLE TONE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; SACCADIC EYE MOVEMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THETA RHYTHM; TREMOR; URINE INCONTINENCE;

ATYPICAL; DAT-SCAN; FRONTOTEMPORAL DEMENTIA; PARKINSONISM; PROGRANULIN;

DIAGNOSIS, DIFFERENTIAL; DOPAMINE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PRESYNAPTIC TERMINALS;

EID: 84890536503     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131151     Document Type: Article

References (27)

1. Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M, Chow TW, Rosen HJ, Forstl H, Kurz A, Miller BL (2005) Frontotemporal lobar degeneration: Demographic characteristics of 353 patients. Arch Neurol 62, 925-930.
2. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review. J Neurol Neurosurg Psychiatry 82, 476-486.
3. Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, Mackenzie IR, Martins RN, Kwok JB, Halliday GM, Kril J, Schofield PR, Mann DM, HuttonM(2006) Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain 129, 3124-3126.
4. Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerrière A, De Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L, Vercelletto M, Thomas-Antérion C, Michel BF, GolfierV, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van Broeckhoven C, Brice A, French Research Network on FTD/FTD-MND (2007) Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 28, 846-855.
5. Kelley BJ, Haidar W, Boeve BF, Baker M, Graff-Radford NR, Krefft T, Frank AR, Jack CR Jr, Shiung M, Knopman DS, Josephs KA, Parashos SA, Rademakers R, Hutton M, Pickering-Brown S, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, Ivnik RJ, Petersen RC (2009) Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 30, 739-751.
6. van Swieten JC, Heutink P (2008) Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 7, 965-974.
7. Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, de la Sayette V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert JC, Verpillat P, Campion D, Habert MO, Dubois B, Brice A, French research network on FTD/FTD-MND (2008) Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain 131, 732-746.
8. Yu C, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM (2010) The spectrum of mutations in progranulin. A collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67, 161-170.
9. Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, Dickson DW (2007) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 66, 142-151.
10. Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, Warrington EK, Stevens J, Revesz T, Holton J, Al-Sarraj S, King A, Scahill R, Warren JD, Fox NC, Rossor MN, Collinge J, Mead S (2008) A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 131, 706-720.
11. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G (2008) Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71, 1235-1239.
12. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff- Radford NR, Rademakers R (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132, 583-591.
13. Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F, Venturelli E, Restelli I, Cantoni C, Bresolin N, Monaco F, Scarpini E, Galimberti D (2009) Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease. J Neurol Sci 287, 291-293.
14. Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nägga K, And reasen N, Davidsson P, Vanmechelen E, Blennow K (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values. Clin Chem 47, 1776-1781.
15. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White CL, 3rd, WoodruffB, Caselli R, Hsiung GY, Feldman H, Knopman D, Hutton M, Rademakers R (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15, 2988-3001.
16. Boeve BF, Baker M, Dickson DW, Parisi JE, Giannini C, Josephs KA, Hutton M, Pickering-Brown SM, Rademakers R, Tang-Wai D, Jack CR Jr, Kantarci K, Shiung MM, Golde T, Smith GE, Geda YE, Knopman DS, PetersenRC(2006) Frontotemporal dementia and parkinsonism associated with the IVS1+ 1G-> A mutation in progranulin: A clinicopathologic study. Brain 129, 3103-3114.
17. Rohrer JD, Beck J, Warren JD, King A, Al Sarraj S, Holton J, Revesz T, Collinge J, Mead S (2009) Corticobasal syndrome associated with a novel 1048 1049insG progranulin mutation. J Neurol Neurosurg Psychiatry 80, 1297-1298.
18. Benussi L, Ghidoni R, Pegoiani E, Moretti DV, Zanetti O, Binetti G (2009) Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol Dis 33, 379-385.
19. Tremolizzo L, Bertola F, Casati G, Piperno A, Ferrarese C, Appollonio I (2011) Progressive supranuclear palsy-like phenotype caused by progranulin p. Thr272fs mutation. Mov Disord 26, 1964-1966.
20. Kim JY, Kim SY, Kim JM, Kim YK, Yoon KY, Kim JY, Lee BC, Kim JS, Paek SH, Park SS, Kim SE, Jeon BS (2009) Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism. Neurology 72, 1385-1389.
21. Kim JM, Lee JY, Kim HJ, Kim JS, Kim YK, Park SS, Kim SE, Jeon BS (2010) The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry 81, 529-532.
22. Yun JY, LeeWW, Kim HJ, Kim JS, Kim JM, Kim HJ, Kim SY, Kim JY, Park SS, Kim YK, Kim SE, Jeon BS (2011) Relative contribution of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism and ataxia. Parkinsonism Relat Disord 17, 338-342.
23. Su CS, Chang WN, Huang SH, Lui CC, Pan TL, Lu CH, Chuang YC, Huang CR, Tsai NW, Hsieh MJ, Chang CC (2010) Cerebrotendinous xanthomatosis patients with and without parkinsonism: Clinical characteristics and neuroimaging findings. Mov Disord 25, 452-458.
24. Shi CH, Tang BS, Wang L, Lv ZY, Wang J, Luo LZ, Shen L, Jiang H, Yan XX, Pan Q, Xia K, Guo JF (2011) PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology 77, 75-81.
25. Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavía J, Santamaria J, Tolosa E (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A prospective study. Lancet Neurol 10, 797-780.
26. Madeo G, Alemseged F, Di Pietro B, Schillaci O, Pisani A (2013) Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): A case report. Neurol Sci 34, 1475-1477.
27. O'Dowd S, Curtin D, Waite AJ, Roberts K, Pender N, Reid V, O'Connell M, Williams NM, Morris HR, Traynor BJ, Lynch T (2012) C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia alsocauses parkinsonism. Mov Disord 27, 1072-1074.